News
Public · Published
Piper Sandler maintains Axon Enterprise at Overweight, lowers price target to $540 from $561
Piper Sandler kept its Overweight rating on Axon Enterprise but cut its price target to $540 from $561, a 3.7% decrease. The new target implies 41.2% upside from the November 5 closing price of $382.56.
Published:
Updated:
What happened
Piper Sandler kept its Overweight rating on Axon Enterprise but cut its price target to $540 from $561, a 3.7% decrease. The new target implies 41.2% upside from the November 5 closing price of $382.56.
Confirmed
Global impact / market context
The lower target signals a smaller expected share-price gain in Piper Sandler’s view, although its Overweight rating was unchanged. Analyst targets can influence investor expectations and positioning, but the article gives no reason for the cut or evidence of a company-level change.
Analyst inference
The listed analyst targets range from $500 to $800, while Piper Sandler’s latest target is $540. These are analysts’ estimates, not confirmed future share prices; different targets can shape investor expectations but do not establish how Axon’s shares will perform.
Analyst inference
What to watch
- Check whether Piper Sandler explains its lower target in a later note; a stated change in assumptions could clarify what drove the reduced expected share-price gain. Analyst inference
- Compare future analyst targets with the listed $500–$800 range; revisions across firms would indicate whether the current spread of views is narrowing or widening. Analyst inference
- Watch for any change in Piper Sandler’s Overweight rating, which remained in place alongside the lower $540 target in this update. Confirmed
Evidence
- Original source link unavailable